The Effects of N-Methyl Butyrohydroxamic Acid and Other Monohydroxamates on Reperfusion-Induced Damage to Contractile Function in the Isolated Rat Heart

References

• Hearse D. J., Humphrey S. M., Naylor W. G., Slade A., Bordu D. Ultrastructural damage associated with reoxygenation of the anoxic myocardium. Journal of Molecular and Cellular Cardiology 1975; 7: 315–324
   PubMed Web of Science ®Google Scholar
• Bolli R. Oxygen-derived free radicals and post ischemic myocardial dysfunction (“stunned myocardium”). Journal of the American College of Cardiology 1988; 12: 239–249
   PubMed Web of Science ®Google Scholar
• Hearse D. J. Ischemia, reperfusion and the determinants of tissue injury. Cardiovascular Drugs and Therapy 1990; 4: 767–776
   PubMed Web of Science ®Google Scholar
• Shuter S. L., Davies M. J., Garlick P. B., Hearse D. J., Slater T. F. Studies on the effects of antioxidants and inhibitors of radical generation on free radical production in the reperfused rat heart using electron spin resonance spectroscopy. Free Radical Research Communications 1990; 9: 223–232
   PubMed Web of Science ®Google Scholar
• Rice-Evans C., Bruckdorfer K. R. Free radicals, lipoproteins and cardiovascular dysfunction. Molecular Aspects of Medicine 1992; 13: 1–111
   PubMed Web of Science ®Google Scholar
• Arduini A., Eddy L., Hochstein P. Detection of ferryl myoglobin in the isolated ischaemic rat heart. Free Radical Biology and Medicine 1990; 9: 511–513
   PubMed Web of Science ®Google Scholar
• Bolli R., Patel B. S., Jeroudi M. O., Lai E. K., McCay P. B. Demonstration of free radical generation in “stunned myocardium” of intact dogs with the use of the spin trap alpha-phenyl-N-tert-butylnitrone. Journal of Clinical Investigation 1988; 82: 476–485
   PubMed Web of Science ®Google Scholar
• Halliwell B. Use of desferoxamine as a probe for iron dependent formation of ·OH. Biochemical Pharmacology 1985; 34: 229–233
   PubMed Web of Science ®Google Scholar
• Rice-Evans C., Okunade G., Khan R. The suppression of iron release from activated myoglobin by physiological electron donors and desferoxamine. Free Radical Research Communications 1989; 7: 45–54
   PubMed Web of Science ®Google Scholar
• Reddy B. R., Kloner R. A., Przyklenk K. Early pretreatment with desferoxamine limits myocardial ischemia/reperfusion injury. Free Radical Biology and Medicine 1989; 7: 45–52
   PubMed Web of Science ®Google Scholar
• Karawtowska-Prokopczuk E., Czarnowska E., Beresewicz A. Iron availability and free radical induced injury in the isolated ischaemic/reperfused rat heart. Cardiovascular Research 1992; 26: 58–66
   PubMedGoogle Scholar
• Collis C. S., Davies M. J., Rice-Evans C. N-hexano-N-methyl hydroxamate, a novel drug, attenuates reperfusion induced contracture in the isolated perfused rat heart. Journal of Physiology 1993; 459: 359P
   Google Scholar
• Bolli R., Patel B. S., Jeroudi M. O., Li X.-Y., Triana J. F., Lai E. K., McCay P. B. Iron-mediated radical reactions upon reperfusion contribute to myocardial “stunning”. American Journal of Physiology 1990; 259: H1901–1911
   PubMed Web of Science ®Google Scholar
• Bolli R., Jeroudi M. O., Patel B. S., Aruoma O. I., Halliwell B., Lai E. K., McCay P. B. Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Circulation Research 1989; 65: 607–622
   PubMed Web of Science ®Google Scholar
• Bolli R., Patel B. S., Zhu W.-X., O'Neill P. G., Hartley C. J., Charlat M. L., Roberts R. The iron chelator desferrioxamine attenuated postischaemic ventricular dysfunction. American Journal of Physiology 1987; 253: H1372–H1380
   Google Scholar
• Myers C. L., Weiss S. J., Kirsh M. M., Shepard B. M., Shlafer M. Effects of supplementing hypothermic crystalloid cardioplegic solution with catalase, superoxide dismutase, allopurinol or desferrioxamine on functional recovery of globally ischaemic and reperfused hearts. Journal of Thoracic and Cardiovascular Surgery 1986; 91: 281–289
   PubMed Web of Science ®Google Scholar
• Maxwell M. P., Hearse D. J., Yellon D. M. Inability of desferrioxamine to limit tissue injury in the ischaemic and reperfused rabbit heart. Journal of Cardiovascular Pharmacology 1989; 13: 608–615
   PubMed Web of Science ®Google Scholar
• Galinanes M., Hearse D. J. Diltiazem and/or desferrioxamine administered at the time of reperfusion fail to improve post-ischaemic recovery in the isolated rat heart after long term hypothermic storage. Journal of Molecular and Cellular Cardiology 1990; 22: 1211–1220
   PubMedGoogle Scholar
• Reddy B. R., Wynne J., Kloner R. A., Przyklenk K. Pretreatment with the iron chelator desferrioxamine fails to provide sustained protection against myocardial ischaemia-reperfusion injury. Cardiovascular Research 1991; 25: 711–719
   PubMedGoogle Scholar
• Rice-Evans C., Baysal E., Singh S., Jones S., Jones J. G. The interaction of desferrioxamine and hydroxypyridone compounds with haemoglobin and erythrocytes. FEBS Letters 1989; 256: 17–20
   PubMedGoogle Scholar
• Lloyd J., Cable H., Rice-Evans C. Evidence that desferrioxamine cannot enter cells by passive diffusion. Biochemical Pharmacology 1991; 41: 1361–1363
   PubMed Web of Science ®Google Scholar
• Pitt C. G., Gupta G., Estes W. E., Rosenkrantz H., Metterville J. J., Crumbliss A. L., Palmer R. A., Norquest K. W., Sprinkle Hardy K. A., Whitcomb D. R., Byers B. R., Arceneaux J. E.L., Gaines C. G., Sciortino C. V. The selection and evaluation of new chelating agents for the treatment of iron overload. Journal of Pharmacology and Experimental Therapeutics 1979; 208: 12–18
   PubMed Web of Science ®Google Scholar
• Green E. S.R., Rice-Evans C., Davies M. J., Cooper C. Protection against myoglobin-induced low density lipoprotein oxidation. Biochemical Society Transactions 1993, In press
   Google Scholar
• Green E. S.R., Evans H., Rice-Evans P., Davies M. J., Salah N., Rice-Evans C. The efficacy of monohydroxamates as free radical scavenging agents compared with di- and tri-hydroxamates. Biochemical Pharmacology 1993; 45: 375–366
   PubMedGoogle Scholar
• Dunnett C. W. New tables for multiple comparisons with a control. Biometrics 1964; 20: 482–491
   Web of Science ®Google Scholar
• Ulrich H., Sayigh A. A.R. Hydroxyamine-derivatives from formaldehyde. Their reaction with acyl halides. Journal of the Chemical Society 1963; 1098–1101
   Google Scholar
• Kukreja R. C., Hess M. L. The oxygen free radical system: from equations through membrane-protein interactions to cardiovascular injury and protection. Cardiovascular Research 1992; 26: 641–655
   PubMed Web of Science ®Google Scholar
• Halliwell B., Gutteridge J. M.C. Free Radical Biology & Medicine (2nd Edit.). Clarendon Press, Oxford 1989
   Google Scholar
• Kukreja R. C., Weaver A. B., Hess M. L. Sarcolemmal Na+ -K+ -ATPase: activation by neutrophil-derived free radicals and oxidants. American Journal of Physiology 1990; 259: H1330–H1336
   Google Scholar
• Halliwell B., Gutteridge J. M.C. Oxygen toxicity, oxygen radicals transition metals and disease. Biochemical Journal 1984; 219: 1–14
   PubMed Web of Science ®Google Scholar
• Drexel H., Durozak E., Kirchmair W., Miulz M., Puschendorf B., Dienstl F. Myoglobinaemia in the early phase of acute myocardial infarction. American Heart Journal 1983; 105: 641–651
   Google Scholar
• Gutteridge J. M.C. Iron promoters of the Fenton reaction and lipid, peroxidation can be released from haemoglobin by peroxides. FEBS Letters 1986; 201: 291–295
   PubMed Web of Science ®Google Scholar
• Hallaway P. E., Eaton J. W., Panter S. S., Hedlund B. E. Modulation of deferoxamine toxicity and clearance by covalent attachment to biocompatible polymers. Proceedings of the Academy of Science USA 1989; 86: 10108–10112
   PubMed Web of Science ®Google Scholar
• Borg D. C., Schaich K. M. Prooxidant action of desferrioxamine: Fenton-like production of hydroxyl radicals by reduced ferrioxamine. Free Radical Biology and Medicine 1986; 2: 237–243, 1986
   Google Scholar
• Smith E. F., Egan J. W., Bugelski P. J., Hillegass L. M., Hill D. E., Griswold D. F. Temporal relationship between neutrophil accumulation and myocardial reperfusion injury. American Journal of Physiology 1988; 255: H1060–H1068
   Google Scholar
• Turner J. J.O, Rice-Evans C., Davies M. J., Newman E. S.R. The formation of free radicals by cardiac myocytes under oxidative stress and the effects of electron donating drugs. Biochemical Journal 1991; 277: 833–837
   PubMed Web of Science ®Google Scholar
• McCord J. Oxygen-derived free radicals in post-ischaemic tissue injury. New England Journal of Medicine 1985; 312: 159–163
   PubMed Web of Science ®Google Scholar
• Turrens J. K., Freeman B., Crapo J. D. Hypoxia increases H2O2 release by lung mitochodria and microsomes. Archives of Biochemistry and Biophysics 1982; 217: 411–421
   PubMed Web of Science ®Google Scholar
• Chambers D. E., Parks D. A., Patterson G., Roy R., McCord J. M., Oshida S., Parmley L. F., Downey J. M. Xanthine oxidase as a source of free radical damage in myocardial ischaemia. Journal of Molecular and Cellular Cardiology 1985; 17: 145–152
   PubMed Web of Science ®Google Scholar
• Ferrari R., Ceconi C., Curello S., Cargnoni A., Alfieri O., Pardini A., Marzollo P., Visioli O. Oxygen free radicals and myocardial damage: protective role of thiol-containing agents. American Journal of Medicine 1991; 91: 3C-95S–3C-105S
   Google Scholar
• Jolly S. R., Kane W. J., Bailie M. B., Abrams G. D., Lucchesi B. R. Canine myocardial reperfusion injury: its reduction by the combined adminstration of superoxide dismutase and catalase. Circulation Research 1984; 54: 277–285
   PubMed Web of Science ®Google Scholar
• Forman M. B., Puett D. W., Cates C. U., McCrosky D. E., Beckman J. K., Greene H. L., Virmani R. Gluthathione redox pathway and reperfusion injury. Circulation 1988; 7: 202–213
   Google Scholar
• Omar B., McCord J., Downey J. Ischaemia-Reperfusion. Oxidative Stress, H. Sies. Academic Press, London and New York 1991; 493–527
   Google Scholar
• Myers C. L., Weiss S. J., Kirsch M. M., Schlafer M. Involvement of hydrogen peroxide and hydroxyl radical in the oxygen paradox: reduction of creatine kinase release by catalase, allopurinol or deferoxamine but not by superoxide dismutase. Journal of Molecular and Cellular Cardiology 1985; 17: 675–685
   PubMed Web of Science ®Google Scholar
• Menasche P., Grousset C., Gauduel Y., Mouas C., Piwnica A. Maintenance of the myocardial thiol pool by N-acetylcysteine. An effective means of improving cardioplegic protection. Journal of Thoracic and Cardiovascular Surgery 1992; 103: 936–944
   PubMed Web of Science ®Google Scholar
• Nejima J., Knight D. R., Fallon J. T., Uemura N., Manders W. T., Canfield D. R., Cohen M. V., Vatner S. F. Superoxide dismutase reduces reperfusion arrhythmias but fails to salvage regional function or myocardium at risk in conscious dogs. Circulation 1989; 79: 143–153
   PubMed Web of Science ®Google Scholar